ArticlePharmacognosy magazine2017
Antihyperglycemic Activity of
Article in Pharmacognosy magazine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.
- The use of Caralluma fimbriata as an appetite suppressant and weight loss supplement: a systematic review and meta-analysis of clinical trials.BMC complementary medicine and therapies · 2021Pooled it
- Exploring the therapeutic potential ofToxicology research · 2024Article
- Antioxidant and Hypoglycemic Potential of Phytogenic Selenium Nanoparticle- and Light Regime-MediatedACS omega · 2024Article
- Article
- Delving the Role ofOxidative medicine and cellular longevity · 2022Review
- Inhibition mechanism of alpha-amylase, a diabetes target, by a steroidal pregnane and pregnane glycosides derived fromFrontiers in molecular biosciences · 2022Article
- PlantFrontiers in endocrinology · 2022Review
- Antidiabetic and antihyperlipidemic effect ofSaudi journal of biological sciences · 2020Article
- Inhibition ofEvidence-based complementary and alternative medicine : eCAM · 2018Article
- Antidiabetic Activity of Ajwain Oil in DifferentJournal of pharmacy & bioallied sciencesArticle
- Aqueous extract ofAvicenna journal of phytomedicineArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAn increase in prevalence of diabetes mellitus necessitates the need to develop new drugs for its effective management. Plants and their bioactive compounds are found to be an alternative therapeutic approach.
objectiveThe present study was designed to investigate the antihyperglycemic effect of the ethanolic leaf extract of MATERIALS AND
methodsDifferent concentrations (1-1000 mg/mL) of the ethanolic leaf extract of
resultsThe
conclusionThe study concludes that SUMMARY: Caralluma fimbriata extract exhibited effective dose dependent inhibitory activity against alpha-amylase and alpha- glucosidaseEnhanced glucose uptake from L6 myotubes was appreciated in the presence of the extract, comparable to Insulin and metforminCaralluma fimbriata has potent antihyperglycemic properties.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.